Keurig Dr Pepper Inc. reported its third quarter 2026 results, showing a 70.6% increase in net sales to $7.3 billion, largely driven by the JDE Peet's acquisition. Diluted EPS rose 20.4% to $0.59 on a GAAP basis, and the company reaffirmed its full-year guidance expecting net sales between $25.9 billion and $26.4 billion. Shareholders can note positive growth across segments alongside ongoing preparation for corporate separation milestones.
Q3 net sales increased 70.6% year-over-year to $7.3 billion, with legacy KDP net sales up 8.6%.
GAAP diluted EPS grew 20.4% to $0.59, while Adjusted diluted EPS increased 22.2% to $0.66.
Full-year 2026 guidance was reaffirmed at $25.9 billion to $26.4 billion in net sales.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Keurig Dr Pepper's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$16.60B
+8.2%
$1.53
+45.7%
12.5%
FY2024
$15.35B
+3.6%
$1.05
-32.3%
9.4%
FY2023
$14.81B
+5.4%
$1.55
+53.5%
14.7%
FY2022
$14.06B
+10.8%
$1.01
-32.7%
10.2%
FY2021
$12.68B
+9.2%
$1.50
+61.3%
16.9%
Frequently asked questions
When is Keurig Dr Pepper's next earnings date?
Keurig Dr Pepper has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Keurig Dr Pepper earn last quarter?
For the quarter ended Sep 2026, Keurig Dr Pepper reported diluted EPS of $0.59 (+20.4% year over year) on revenue of $7.34B (+70.6%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.